Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment
Background: Chrysin (5,7-dihydroxyflavone) is a natural flavonoid that has been reported as a potential treatment for non-alcoholic fatty liver disease (NAFLD).